Search For "controller"
Anti-viral drug favipiravir gets DGCI nod for 'restricted emergency use' i
Updated : 5 years, 9 months ago IST
New Delhi [India], June 19 (ANI): The Drug Controller General of India (DCGI) has granted permission to anti-viral drug favipiravir for "restricted emergency use" in mild to moderate cases of COVID-19, a senior government official confirmed to ANI.
Read More
Sun Pharma initiates phase two clinical trial on AQCH as potential treatme
Updated : 5 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 5 (ANI): Sun Pharmaceutical Industries has started phase two clinical trial on AQCH, a phytopharmaceutical (plant-derived) drug for the treatment of COVID-19.
Read More
Remdesivir effective in treating critical COVID-19 patients, says senior p
Updated : 5 years, 9 months ago IST
New Delhi [India], June 4 (ANI): Former honorary physician to the President of India and senior physician at Ganga Ram hospital Dr Mohsin Wali has welcomed the move of the Drug Controller General of India to give permission for emergency use of Remdesivir to treat COVID-19 patients and sa
Read More
COVID-19: Pharma giants seek DCGI's approval to manufacture, sell Remdesiv
Updated : 5 years, 9 months ago IST
New Delhi [India], June 4 (ANI): Two domestic pharmaceutical firms--Mylan and Jubilant Life Sciences have approached the country's top drug regulator--Drug Controller General of India (DCGI) to seek its approval to manufacture and sell anti-viral drug 'Remdesivir' in India to combat COVID-19
Read More
COVID-19: Remdesivir gets nod from CDCSO for 'restricted emergency use' on
Updated : 5 years, 9 months ago IST
New Delhi [India], June 2 (ANI): In a significant development, the country's top drug controller the Central Drug Control Standard Organisation (CDCSO) has given permission to Gilead Sciences for marketing authorization of its anti-viral drug Remdesivir "only for restricted emergency use" o
Read More
Sun Pharma gets DCGI approval for clinical trial with Nafamostat in Covid-
Updated : 5 years, 9 months ago IST
Mumbai (Maharashtra) [India], May 29 (ANI): Sun Pharmaceutical Industries said on Friday it has received approval from the Drugs Controller General of India (DCGI) to initiate clinical trial with Nafamostat Mesilate in Covid-19 patients.
Read More
Panjab University issues SOPs to conduct semester exams from July
Updated : 5 years, 9 months ago IST
Chandigarh (Panjab) [India], May 29 (ANI): Panjab University Exam Controller Dr Parvinder Singh informed that the varsity has finalised standard operative procedures (SOPs) to conduct exams for exit classes from July.
Read More
Here's why Zoom is asking users to upgrade app before May 30
Updated : 5 years, 9 months ago IST
California [US], May 28 (ANI): The video communications company Zoom made an announcement recently urging Zoom Rooms admins and users to update their app for new enhanced features and security updates that arrived with its release Zoom 5.0, before May 30.
Read More
Glenmark begins phase 3 of clinical trials on antiviral Favipiravir for CO
Updated : 5 years, 10 months ago IST
Mumbai (Maharashtra) [India], May 12 (ANI): Glenmark Pharmaceuticals has initiated phase three of clinical trials in India on antiviral tablet Favipiravir, becoming the first company in the country to do so.
Read More
CSIR to begin two clinical drug trials to combat COVID-19
Updated : 5 years, 10 months ago IST
New Delhi [India], May 8 (ANI): The Council for Scientific and Industrial Research (CSIR) has received approval from Drug Controller General of India (DGCI) for its two clinical trial drugs - 'favipiravir' and 'phytopharmaceutical' - to combat coronavirus.
Read More
Google's Stadia controller to finally work wirelessly with computers start
Updated : 5 years, 10 months ago IST
Washington D.C. [USA], May 6 (ANI): Google has announced that its Stadia Controller will finally work wirelessly with laptops and desktops starting this week.
Read More
Zydus Cadila approaches DCGI to use hepatitis drug for COVID-19 clinical t
Updated : 5 years, 10 months ago IST
New Delhi [India], May 5 (ANI): The country's top drug regulator, Drug Controller General of India (DCGI), has received an application from Zydus Cadila, the leading global pharmaceutical company in India, to conduct clinical trial using antiviral drug 'Pegylated Interferon Alpha-2b' in adul
Read More